Researchers at the University of Virginia School of Medicine say this finding could open the door to better ways to manage high blood pressure and other vascular diseases.
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...